Kidney cancer detected early with urine test

Finding it early has been among the disease’s greatest challenges. Evan D. Kharasch, MD, PhD and Jeremiah J. Morrissey, PhD, have developed a noninvasive method to screen for kidney cancer.

Read More

Laughing gas studied as depression treatment

Nitrous oxide has shown early promise as a treatment for severe depression in patients whose symptoms don’t respond to standard therapies, according to a pilot study at Washington University.

Read More

Evan D. Kharasch, MD, PhD to deliver the John W. Severinghaus Lecture on Translational Science

Kharasch, will deliver his lecture entitled ‘Basic Science to Clinical Practice: The Tale of Long-Acting Opioids’ at the ANESTHESIOLOGY 2014 Annual Meeting

Read More

Kharasch elected to Institute of Medicine

Evan D. Kharasch, MD, PhD has been elected to the Institute of Medicine of the National Academy of Sciences, one of the highest honors medical scientists in the United States can receive.

Read More

Evan Kharasch, MD, PhD awarded a $2.8 million FDA/NIH U01 Grant

Only one grant was awarded nationally to study the clinical effectiveness and safety of the antidepressant drug bupropion and enhance the psychiatric care for the more than 1 million Americans.

Read More
< Older Publications